Pharmacology of the pyrroloimidazole, SK&F 105809—I: Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid
- 25 July 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (4) , 813-824
- https://doi.org/10.1016/0006-2952(91)90041-3
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Role of Cytokines in the Development of OsteoarthritisScandinavian Journal of Rheumatology, 1990
- Effect of the oral leukotriene D antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D in atopic subjectsJournal of Allergy and Clinical Immunology, 1989
- Leukotrienes: Regulation of Biosynthesis, Metabolism, and BioactivityThe Journal of Clinical Pharmacology, 1988
- Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002International Journal of Immunopharmacology, 1988
- Indomethacin increases the formation of lipoxygenase products in calcium ionophore stimulated human neutrophilsBiochemical and Biophysical Research Communications, 1987
- Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep.The Journal of Experimental Medicine, 1986
- Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agentsInflammation Research, 1985
- CHEMOTACTIC LIPOXYGENASE PRODUCTS IN PSORIASISThe Lancet, 1983
- Leukotriene B4General Pharmacology: The Vascular System, 1981
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959